Markman Advisors
Patent Valuation, Monetization and Investments

Blog

Markman Advisors Patent Blog

by Zachary Silbersher

Posts tagged ONPATTRO
What is Alnylam’s Covid patent lawsuit against Moderna and Pfizer all about?

Moderna faces a new patent lawsuit related to its Covid vaccine. On March 17, Alnylam Pharmaceuticals commenced two separate patent lawsuits—one against Moderna and another against Pfizer. Both suits claim that the Covid manufacturers’ vaccines are infringing a patent owned by Alnylam. So what are Alnylam’s lawsuits all about?

Read More
Markman AdvisorsAlnylam, Alnylam Pharmaceuticals, Moderna, Moderna Therapeutics, Pfizer, $MRNA, mRNA, $PFE, PFE, MRNA, Arbutus, $ABUS, ABUS, ALNY, $ALNY, vaccine, patent, LNP, lipid, lipid nanoparticle, cationic lipid, nucleic acid, ALC-0315, SM-102, Zachary Silbersher, Silbersher, ONPATTROComment